K-Pop event firm’s shares remain suspended as losses continue to spiral February 6, 2024 Live Company, the firm behind children’s live entertainment group Bricklive and K-Pop Lux has published its 2022 financial accounts after a six month delay which resulted in it being suspended from the London Stock Exchange. Back in July, the Surrey based group was told it could no longer trade because it failed to publish its [...]
GSK announces breakthrough with blood cancer treatment drug Blenrep February 6, 2024 Biotech giant GSK has announced a potential breakthrough in the treatment of relapsed or refractory multiple myeloma, a type of blood cancer.
Bank of England: Rate cuts when not if but Brits must wait for their ‘reward’ February 6, 2024 The Bank of England’s chief economist Huw Pill has said interest rate cuts are a matter of “when” rather than “if” policymakers want to “reward the economy” for progress on inflation.
Augmentum leads fresh investment round in London insurtech Artificial Labs February 6, 2024 It will also look to entrench its position as in algorithmic underwriting software, as insurance increasingly looks towards 'digital solutions', an update to the markets said this morning.
UBS reinstates dividend and plans share buyback despite second consecutive quarterly loss February 6, 2024 UBS has announced that it will resume share buybacks in the second half of this year and plans to award shareholders up to $1bn (£797m) as it integrates fallen rival Credit Suisse.
Brits stayed at home to watch The Traitors during Dry January in blow for pubs February 6, 2024 Restaurants were hit harder with spending declining 11.6 per cent widening from 8.8 per cent on a month on month basis.
UK government to prepare regulators for AI as it eyes ‘agile’ approach February 6, 2024 The British government will spend more than £100m building artificial intelligence (AI) research hubs and preparing regulators.
Cazoo founder and state-backed investor drive £76m injection into AI fund February 6, 2024 The state-backed investor British Patient Capital and founder of troubled car firm Cazoo have backed a £76m injection into an London-based venture capital firm as it gears up for a spate of AI investment in the coming months.
In Good Company CEO: What I learnt leaving the corporate climb behind February 6, 2024 A good corporate job wasn't enough for Alex Birtles, so she packed it in to do her own thing. She tells Jennifer Sieg why.
Investors’ greenwashing fears must lead to greater City scrutiny February 6, 2024 About three years ago we hit on a seemingly foolproof strategy: we agreed to ask about the City’s three favourite letters: ESG.
